Starling Oncology, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2025-04-08: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-03-26; Total offering amount $16,444,699.
- 2022-08-24: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2022-08-09; Total offering amount $110,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2025-04-08 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2025-03-26 | $16,444,699 | $16,444,699 | $0 | 14 |
| 2022-08-24 | Rule 506(b) | Debt; OptionToAcquire; SecurityToBeAcquired | 2022-08-09 | $110,000,000 | $110,000,000 | $0 | 3 |